Products

Anti-VEGF × Anti-OPN Bispecific Antibody (TAND-L017)

Recombinant Anti-VEGF × Anti-OPN Bispecific Antibody (TandAb) is a bispecific fusion protein with four binding sites, two of which bind to tumor cell surface antigens and the other two to the immune cells. TandAbs do not carry Fc domains. So they are smaller than whole IgGs or IgG-derived BsAbs but larger than BiTEs. Therefore, they have a shorter serum half-life than IgGs but remain longer in the circulation compared with BiTEs. This BsAb is capable of inhibiting signaling of their cognate receptors and a combined blockade of them has a greater inhibitory efficacy compared with inhibition of either factor alone. It was designed for the treatment of hepatocellular carcinoma, metastatic cancer.      

Specifications
Targets
VEGF & OPN
Type
TandAb
Expression Host
CHO
Species Reactivity
Human
Target 1
VEGF
Host
Human
Target 2
OPN
Host
Human
Purity
>95% judged by SDS-PAGE under reducing condition
Applications
FuncS, Promising therapeutic agent
Related Disease
Hepatocellular carcinoma; Metastatic cancer
Targets
Target 1
VEGF
Gene ID
7422
UniProt ID
P15692
Alternative Names
VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor
Target 2
OPN
Gene ID
6696
UniProt ID
A0A024RDE6
Alternative Names
OPN; BNSP; BSPI; ETA-1

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved